As smoking rates fall across the country, the percentage of New Yorkers smoking is actually on the rise, up from 14 percent in 2010 to 16 percent in 2013. Although lower than the national average of 18 percent, the findings
Harm Reduction
Gov. Nixon s e-cigarette veto: harming smokers, not protecting kids
Gilbert Ross, M.D
The American Council on Science and Health
The Lancet just had to get its word in on the e-cigarette controversy. Its editorial written we re sure by editor-in-chief Richard Horton toes the W.H.O. line of alarmism and hyper-precaution about this ground-breaking technology. No surprise, given his history.
In an effort to emphasize its commitment to healthcare, CVS Caremark will now be known as CVS Health at its 7,700 drugstores. CVS CEO Larry Merlo says, We're doing more and more to extend the front
New policy statements from the WHO, the AHA, and the CDC spew baseless, distorted allegations, warning smokers not to try e-cigarettes and spreading false concerns about second-hand vapor. They should be ashamed for selling out.
The latest health news: India and China take many steps backward in GMO advancements, E-cig company fights back, and why eating or skipping breakfast may not affect your weight
An e-cig/vapor company takes on the misguided EU Tobacco Products Directive. They only have science, the EU s own treaties, and common sense behind them, but it will still be an uphill battle to save smokers.
As discussed in a TIME magazine article, a newly-released survey (by Kantar Media, called their annual MARS Consumer Health Study) shows that smokers have taken to quitting by using e-cigarettes with a devotion that
NCar docs are ignoring the dire warnings of health officials and politicians by suggesting to their smoking patients to try e-cigarettes to help them quit. Unlike those demagogues, docs have to actually try to help.
The latest health news: A malaria drug effective in infants, why physicians are recommending e-cigs to patients, and why you shouldn't worry about a link between psoriasis and certain cancers
Two new additions to the growing scientific (as opposed to the ideological) literature on reduced-risk nicotine products (e-cigarettes in shorthand) show more clearly their high likelihood of benefiting smokers trying to quit smoking.
Catch the latest news on concerns regarding Gilead's $84,000 hepatitis C treatment drug Sovaldi, the declining sales of traditional cigarettes, and why prior authorization could be hurting the health care system